Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient with growth hormone deficiency,~  1. Diagnosis of growth hormone deficiency proven by appropriate exploration~ 2. Size ≤ -2 Standard Deviation (SD) according to the French references~ 3. Growth velocity in the previous year inferior to the normal for age (-1SD) or \< 4cm/year~* Growth deficiency due to Turner's syndrome~  1. Turner's syndrome confirmed by a karyotype~ 2. Patient's size ≤ -2 SD according to the French references~ 3. Bone age \< 12 years~* Patient who require a minimum of 18 months of treatment.~Exclusion Criteria:~* There are no exclusion criteria except the contraindication for Zomacton® 10 mg

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Zomacton® treatment with Zomajet® Vision X device (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).